Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Anil Rajani

Family Medicine Hood River, OR Medical Doctor

NPI 1245241173 CMS profile 146718

1327 Columbia St, Hood River, OR 97031

Open in the dashboard

General payments

$325,269

303 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Anil Rajani of Hood River, OR is reported in the CMS Open Payments database as having received $325,269 across 303 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Family Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $8,694 12
2024 General $22,712 14
2023 General $25,990 23
2022 General $46,630 25
2021 General $38,680 35
2020 General $103,562 45
2019 General $79,001 149

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Anil Rajani
  • Family Medicine median
  • Middle half of Family Medicine
  • National median

In program year 2025, general payments to Anil Rajani were reported at $8,694. Among 56,786 Family Medicine profiles paid that year, the median was $155 and the middle half received between $45 and $549.

Show as a table
Year Anil Rajani Family Medicine median Middle half National median
2019 $79,001 $150 $41–$543 $163
2020 $103,562 $120 $32–$415 $114
2021 $38,680 $137 $35–$551 $132
2022 $46,630 $137 $37–$512 $149
2023 $25,990 $149 $42–$545 $160
2024 $22,712 $156 $44–$560 $164
2025 $8,694 $155 $45–$549 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Galderma Laboratories, L.P. $313,325 259 payments
  2. Merz North America, Inc. $9,643 21 payments
  3. Allergan Inc. $2,055 20 payments
  4. AbbVie, Inc. $245 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $249,655 71 payments
  2. Consulting Fee $45,627 11 payments
  3. Travel and Lodging $21,976 83 payments
  4. Food and Beverage $7,107 119 payments
  5. Education $904 19 payments
Products named General payments · program years 2019–2025
  1. Xeomin $9,459 19 payments
  2. BOTOX $1,252 3 payments
  3. DYSPORT $556 6 payments
  4. BOTOX COSMETIC $431 9 payments
  5. DYSPORT $161 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

303 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Family Medicine in Oregon

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record